Hua‐Kang Wu

444 total citations
15 papers, 348 citations indexed

About

Hua‐Kang Wu is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Hua‐Kang Wu has authored 15 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Hematology and 4 papers in Genetics. Recurrent topics in Hua‐Kang Wu's work include Angiogenesis and VEGF in Cancer (6 papers), Genetic Syndromes and Imprinting (3 papers) and Epigenetics and DNA Methylation (3 papers). Hua‐Kang Wu is often cited by papers focused on Angiogenesis and VEGF in Cancer (6 papers), Genetic Syndromes and Imprinting (3 papers) and Epigenetics and DNA Methylation (3 papers). Hua‐Kang Wu collaborates with scholars based in United States, Canada and Germany. Hua‐Kang Wu's co-authors include Rosanna Weksberg, Jeremy A. Squire, Mark D. Minden, Changyi Chen, Alan B. Lumsden, Peter H. Lin, Brian S. Conklin, John V. Heymach, Qizhi Yao and Peter Hu and has published in prestigious journals such as Cancer, Biochemical and Biophysical Research Communications and Cancer Letters.

In The Last Decade

Hua‐Kang Wu

15 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hua‐Kang Wu United States 11 178 88 62 58 55 15 348
Nathalie Wunderlich Germany 13 265 1.5× 140 1.6× 34 0.5× 92 1.6× 33 0.6× 17 554
Shengquan Huang China 15 176 1.0× 44 0.5× 51 0.8× 32 0.6× 32 0.6× 24 465
Asako Tajima United States 12 158 0.9× 45 0.5× 57 0.9× 98 1.7× 29 0.5× 18 450
Hima V. Vangapandu United States 12 241 1.4× 72 0.8× 35 0.6× 57 1.0× 15 0.3× 17 460
Pam Pritzl United States 9 129 0.7× 64 0.7× 40 0.6× 23 0.4× 61 1.1× 9 461
Jeesoo Chae South Korea 13 119 0.7× 99 1.1× 98 1.6× 53 0.9× 20 0.4× 26 419
Yongli Chu China 13 183 1.0× 28 0.3× 42 0.7× 31 0.5× 15 0.3× 39 489
Yu Qin China 12 105 0.6× 26 0.3× 27 0.4× 58 1.0× 16 0.3× 18 306
Mancheng Gong China 12 220 1.2× 28 0.3× 55 0.9× 81 1.4× 12 0.2× 21 520
Soon‐Keng Cheong Malaysia 12 225 1.3× 23 0.3× 140 2.3× 38 0.7× 34 0.6× 35 450

Countries citing papers authored by Hua‐Kang Wu

Since Specialization
Citations

This map shows the geographic impact of Hua‐Kang Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hua‐Kang Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hua‐Kang Wu more than expected).

Fields of papers citing papers by Hua‐Kang Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hua‐Kang Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hua‐Kang Wu. The network helps show where Hua‐Kang Wu may publish in the future.

Co-authorship network of co-authors of Hua‐Kang Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Hua‐Kang Wu. A scholar is included among the top collaborators of Hua‐Kang Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hua‐Kang Wu. Hua‐Kang Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Wu, Hua‐Kang, et al.. (2021). Liquid–Liquid Equilibrium Data for Cyclohexane–Ethanol–Solvent Ternary Systems and Their Correlation with the Nonrandom Two-Liquid Model. Journal of Chemical & Engineering Data. 66(12). 4384–4390. 4 indexed citations
3.
Bhatt, Rupal S., Jaime R. Merchan, Robert Parker, et al.. (2010). A phase 2 pilot trial of low‐dose, continuous infusion, or “metronomic” paclitaxel and oral celecoxib in patients with metastatic melanoma. Cancer. 116(7). 1751–1756. 57 indexed citations
4.
Zurita, Amado J., Eric Jonasch, Hua‐Kang Wu, Hai T. Tran, & John V. Heymach. (2009). Circulating biomarkers for vascular endothelial growth factor inhibitors in renal cell carcinoma. Cancer. 115(S10). 2346–2354. 17 indexed citations
5.
Wu, Hua‐Kang, Hongli Chen, & Peter Hu. (2007). Circulating endothelial cells and endothelial progenitors as surrogate biomarkers in vascular dysfunction.. PubMed. 53(5-6). 285–95. 20 indexed citations
6.
Wu, Hua‐Kang, Gordon M. Riha, Hui Yang, et al.. (2005). Differentiation and Proliferation of Endothelial Progenitor Cells from Canine Peripheral Blood Mononuclear Cells1,2. Journal of Surgical Research. 126(2). 193–198. 30 indexed citations
7.
Conklin, Brian S., Hua‐Kang Wu, Peter H. Lin, Alan B. Lumsden, & Changyi Chen. (2004). Basic Fibroblast Growth Factor Coating and Endothelial Cell Seeding of a Decellularized Heparin‐coated Vascular Graft. Artificial Organs. 28(7). 668–675. 54 indexed citations
8.
Wu, Hua‐Kang, Qizhi Yao, Alan B. Lumsden, & Changyi Chen. (2004). Characterization of two populations of human coronary artery endothelial cells1. Journal of Surgical Research. 118(1). 38–44. 11 indexed citations
9.
Wu, Hua‐Kang, et al.. (1997). Relaxation of Imprinting of Human Insulin-like Growth Factor II Gene,IGF2,in Sporadic Breast Carcinomas. Biochemical and Biophysical Research Communications. 235(1). 123–129. 43 indexed citations
10.
Wu, Hua‐Kang & Mark D. Minden. (1997). Transcriptional Activation of Human LIM-HOX GenehLH-2in Chronic Myelogenous Leukemia Is Due to acis-Acting Effect ofBcr-Abl. Biochemical and Biophysical Research Communications. 234(3). 742–747. 6 indexed citations
11.
Wu, Hua‐Kang & Mark D. Minden. (1997). Transcriptional Activation of Human LIM-HOX Gene,hLH-2,in Chronic Myelogenous Leukemia Is Due to acis-Acting Effect ofBcr-Abl. Biochemical and Biophysical Research Communications. 233(3). 806–812. 13 indexed citations
12.
Wu, Hua‐Kang, et al.. (1997). Promoter-Dependent Tissue-Specific Expressive Nature of Imprinting Gene, Insulin-like Growth Factor II, in Human Tissues. Biochemical and Biophysical Research Communications. 233(1). 221–226. 22 indexed citations
13.
Wu, Hua‐Kang, Rosanna Weksberg, Mark D. Minden, & Jeremy A. Squire. (1997). Loss of Imprinting of Human Insulin-like Growth Factor II Gene, IGF2, in Acute Myeloid Leukemia. Biochemical and Biophysical Research Communications. 231(2). 466–472. 52 indexed citations
14.
15.
Wu, Hua‐Kang, Shigeru Chiba, Hisamaru Hirai, Fumimaro Takaku, & Yoshio Yazaki. (1994). Effect of stem cell factor (c‐kit ligand) on clonogenic leukemic precursor cells: Synergy with other hematopoietic growth factors. American Journal of Hematology. 47(4). 328–330. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nathalie Wunderlich Breakdown of academic impact, for papers by Shengquan Huang Breakdown of academic impact, for papers by Asako Tajima Breakdown of academic impact, for papers by Hima V. Vangapandu Breakdown of academic impact, for papers by Pam Pritzl Breakdown of academic impact, for papers by Jeesoo Chae Breakdown of academic impact, for papers by Yongli Chu Breakdown of academic impact, for papers by Yu Qin Breakdown of academic impact, for papers by Mancheng Gong Breakdown of academic impact, for papers by Soon‐Keng Cheong
Rankless by CCL
2026